Trending...
- Long Beach Airport Expands Sustainability Efforts - 180
- All Long Beach Open Coastal Swimming Areas Temporarily Closed Due to Local Sewage Spill - 132
- For National Novel Writing Month: Will this be the year my fascinating Novel finally gets Published? - 120
Kira Savin, Au.D., of California Hearing Center on listening effort, why preserving background sound may matter to the brain, and why the larger clinical problem remains the millions of adults who never get treated at all
SAN MATEO, Calif. - Californer -- Oticon today announced Oticon Reveal™, described as the world's first hearing aid powered by "Dual AI." Kira Savin, Au.D., of California Hearing Center, says the news is noteworthy for a design choice, not the AI headline.
"The letters A and I are doing a lot of marketing work right now," Dr. Savin said. "What's actually notable is that instead of deleting background sound, this device keeps and balances it. That's a bet on how the brain works. Whether it pays off is answered in the fitting room, not a press release."
Hearing loss is a brain problem
Modern audiology treats hearing loss as increased cognitive workload. A degraded signal forces the brain to use attention and working memory to reconstruct speech—listening effort that leaves many patients exhausted after social situations.
More on The Californer
Conventional noise reduction can improve intelligibility but removes spatial cues the brain uses to orient. Research links untreated hearing loss to broader risks: the 2024 Lancet Commission lists it among 14 modifiable dementia risk factors (about 7% of cases). The ACHIEVE trial (2023) found no overall cognitive benefit, though a higher-risk subgroup showed a substantial relative reduction in decline. "It did not show hearing aids prevent dementia in everyone," Dr. Savin noted. "Patients deserve the actual result."
Hearing aids are FDA-cleared only to compensate for impaired hearing, not to prevent dementia.
What Oticon announced
Oticon Reveal runs Speech AI (enhancing nearby speech) and Context AI (balancing surrounding sounds) simultaneously. The company claims a 60% stronger brain response and industry-leading speech access, citing unpublished data, plus Bluetooth LE Audio and Auracast™ support. These are manufacturer claims; California Hearing Center has not verified them.
More on The Californer
Most hearing loss still goes untreated
About 1 in 8 Americans aged 12+ has bilateral hearing loss. Only ~16% of adults 20–69 who could benefit have ever used hearing aids; among those 70+, fewer than 1 in 3 have.
"Product launches generate upgrade calls," Dr. Savin said. "Far fewer come from people who have never had an audiogram. The best device does nothing for someone unevaluated—and a poorly fit device can underperform a cheaper one fitted correctly."
California Hearing Center is independent and dispenses multiple brands (Oticon, Phonak, Widex, ReSound, Starkey, Signia) based on clinical need. Real-ear verification is standard.
https://calhearing.com/products/hearing-aids-by-brand/oticon/oticon-reveal/
"The letters A and I are doing a lot of marketing work right now," Dr. Savin said. "What's actually notable is that instead of deleting background sound, this device keeps and balances it. That's a bet on how the brain works. Whether it pays off is answered in the fitting room, not a press release."
Hearing loss is a brain problem
Modern audiology treats hearing loss as increased cognitive workload. A degraded signal forces the brain to use attention and working memory to reconstruct speech—listening effort that leaves many patients exhausted after social situations.
More on The Californer
- Jacko Law Group Recognized by Best Law Firms® for Corporate Law in San Diego
- Happreneurs™ Announces 20 Open Houses Nationwide, Introducing a New Era of Business Networking Built on Happiness
- Holiday Season Jewellery Gift Guide 2026: Designer-Inspired Christmas Gifts for Her That Feel Luxurious
- Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
- Are there any pet-friendly hotels near Redondo Beach, CA?
Conventional noise reduction can improve intelligibility but removes spatial cues the brain uses to orient. Research links untreated hearing loss to broader risks: the 2024 Lancet Commission lists it among 14 modifiable dementia risk factors (about 7% of cases). The ACHIEVE trial (2023) found no overall cognitive benefit, though a higher-risk subgroup showed a substantial relative reduction in decline. "It did not show hearing aids prevent dementia in everyone," Dr. Savin noted. "Patients deserve the actual result."
Hearing aids are FDA-cleared only to compensate for impaired hearing, not to prevent dementia.
What Oticon announced
Oticon Reveal runs Speech AI (enhancing nearby speech) and Context AI (balancing surrounding sounds) simultaneously. The company claims a 60% stronger brain response and industry-leading speech access, citing unpublished data, plus Bluetooth LE Audio and Auracast™ support. These are manufacturer claims; California Hearing Center has not verified them.
More on The Californer
- Where can I find a hotel with meeting and event space near Redondo Beach, CA?
- Can you find a pet-friendly hotel near Manhattan Beach, CA?
- Gum Recession? Pinhole Surgery Explained by Chao Pinhole® Certified Dr. Narkhede, Lake Forest, CA
- I'm looking for a hotel with a fitness center near Manhattan Beach, CA. Any options?
- Where should I stay near Manhattan Beach, CA if I'm flying out of LAX?
Most hearing loss still goes untreated
About 1 in 8 Americans aged 12+ has bilateral hearing loss. Only ~16% of adults 20–69 who could benefit have ever used hearing aids; among those 70+, fewer than 1 in 3 have.
"Product launches generate upgrade calls," Dr. Savin said. "Far fewer come from people who have never had an audiogram. The best device does nothing for someone unevaluated—and a poorly fit device can underperform a cheaper one fitted correctly."
California Hearing Center is independent and dispenses multiple brands (Oticon, Phonak, Widex, ReSound, Starkey, Signia) based on clinical need. Real-ear verification is standard.
https://calhearing.com/products/hearing-aids-by-brand/oticon/oticon-reveal/
Source: California Hearing Center
Filed Under: Medical
0 Comments
Latest on The Californer
- The Truth, The Journey Within Makes Its Worldwide Premiere in Beverly Hills
- Kval introduces the Stinger automatic stop stitcher
- Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
- New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
- Bragabilia Artesian Water Debuts as VIP Lounge Sponsor of the Coronado Island Film Festival
- SD2 Receives $100,000 Grant to Expand STEM Opportunities for San Diego Students
- Brand Identity: Creating a Distinctive Presence in a Competitive Market
- Dental Surgery Solutions: Restoring Oral Health and Function at Coastal Dental Arts in San Diego
- Get Care at Home Partners with PocketRN to Help Dementia Caregivers Find Support at Home
- CareVantage Solutions Adds Five Short Guides and Five Regular Books to The Caregiver Library
- Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
- Thursday's Hair Solutions Launches New Program to Address GLP-1-Related Hair Loss
- Two Moorpark College programs named national Bellwether Award finalists
- G. A. Tierney Expands the Dark Psychological Romance Nadine Wolfe Series with Audiobook and Second Novel, The Cruelty of Desire
- Piper Madison Announces New Single "Don't Be a Stranger" and Launch of 10PM Records
- Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
- GreenSight Joins Character Labs G7, Secures $200K Investment
- IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
- Berkeley Nucleonics Highlights SAM 950 3x3 NaI Detector
- FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc